Aptameric Fluorescent Biosensors for Liver Cancer Diagnosis
Biosensors · 2023
DOI: 10.3390/bios13060617 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biosensors, 2023. Verfasst von Seonga Park und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Convergence Engineering, Pusan National University, Yangsan 50612, Republic of Korea. Hauptthemen laut MEDLINE: Biosensing Techniques, Liver Neoplasms, Aptamers, Nucleotide. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea(NRF) grant funded by the Korea government(MSIT), Kwangwoon University in 2023, National Research Foundation of Korea (NRF).
Abstract (Originalsprache)
Liver cancer is a prevalent global health concern with a poor 5-year survival rate upon diagnosis. Current diagnostic techniques using the combination of ultrasound, CT scans, MRI, and biopsy have the limitation of detecting detectable liver cancer when the tumor has already progressed to a certain size, often leading to late-stage diagnoses and grim clinical treatment outcomes. To this end, there has been tremendous interest in developing highly sensitive and selective biosensors to analyze related cancer biomarkers in the early stage diagnosis and prescribe appropriate treatment options. Among the various approaches, aptamers are an ideal recognition element as they can specifically bind to target molecules with high affinity. Furthermore, using aptamers, in conjunction with fluorescent moieties, enables the development of highly sensitive biosensors by taking full advantage of structural and functional flexibility. This review will provide a summary and detailed discussion on recent aptamer-based fluorescence biosensors for liver cancer diagnosis. Specifically, the review focuses on two promising detection strategies: (i) Förster resonance energy transfer (FRET) and (ii) metal-enhanced fluorescence for detecting and characterizing protein and miRNA cancer biomarkers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biomedical Convergence Engineering, Pusan National University, Yangsan 50612, Republic of Korea.
- Department of Information Convergence Engineering, Pusan National University, Yangsan 50612, Republic of Korea.
- Vitale Biotechnology, Inc., 700 West Park Ave, Perkasie, PA 18944, USA.
- Department of Agricultural Convergence Technology, Jeonbuk National University, Jeonju 54896, Republic of Korea.
- Department of Chemical Engineering, Kwangwoon University, Seoul 01897, Republic of Korea.
- Department of Physiology, School of Medicine, Pusan National University, Yangsan 50612, Republic of Korea.
ORCID-Profile: June-Sun Yoon, Jin-Ho Lee
Förderung
- National Research Foundation of Korea(NRF) grant funded by the Korea government(MSIT)
- Kwangwoon University in 2023
- National Research Foundation of Korea (NRF)
- Korea government (MSIT)
- Kwangwoon University
Zitieren
APA
Park, S., Cho, E., Chueng, S. D., Yoon, J. S., Lee, T., & Lee, J. H. (2023). Aptameric Fluorescent Biosensors for Liver Cancer Diagnosis. Biosensors. https://doi.org/10.3390/bios13060617
Vancouver
Park S, Cho E, Chueng SD, Yoon JS, Lee T, Lee JH. Aptameric Fluorescent Biosensors for Liver Cancer Diagnosis. Biosensors. 2023. doi:10.3390/bios13060617
BibTeX
@article{Park2023,
author = {Park, Seonga and Cho, Euni and Chueng, Sy-Tsong Dean and Yoon, June-Sun and Lee, Taek and Lee, Jin-Ho},
title = {Aptameric Fluorescent Biosensors for Liver Cancer Diagnosis},
journal = {Biosensors},
year = {2023},
doi = {10.3390/bios13060617}
}
EUVIMED